Generic placeholder image

Current Chemical Biology

Author(s): Amuthalakshmi Sivaperuman, Ramalakshmi Natarajan*, Manimegalai P, Arunkumar Subramani and Puratchikody Ayarivan

DOI: 10.2174/2212796815666211026110125

DownloadDownload PDF Flyer Cite As
QSAR Docking on Azoles as Inhibitors of Notum Carboxylesterase

Page: [234 - 248] Pages: 15

  • * (Excluding Mailing and Handling)

Abstract

Background: Carboxylesterase Notum is a negative regulator of Wnt signaling. Notum carboxylesterase is a carboxylic ester hydrolase enzyme that functions as a negative feedback regulator of Wnt proteins by depalmitoylation reaction. It is of great importance to understand the pathway of Wnt regulation because, conversely, misregulation of Wnt signaling is a telltale sign of cancer and other degenerative diseases. The Wnt inhibition is important in the control of colorectal cancer.

Objective: In the present study, we carried out a QSAR analysis of a series of reported compounds with carboxylesterase Notum inhibitory activity using multiple regression analysis. A series of 83 compound datasets of pyrrole derivatives with carboxy Notum inhibitory values were taken from the reported literature.

Methods: The study was performed by conducting multiple linear regression analysis followed by validation of the model. The multiple linear regression (MLR) models with the highest coefficients of correlation (R2) and explained variance in leave-one-out (Q2 LOO) prediction and leave- manyout (Q2 LMO) were selected for the whole dataset. The developed models were subjected to internal and external validation. The reliability of the predicted model was checked by plotting the Williams plot. The docking methodology was performed using Autodock 4 for the designed compounds to study the interaction between the ligand and the receptor.

Results: The best model generated exhibited an r2 value of 0.7413, Q2LOO =0.6379, Q2LMO =0.6368. Novel compounds of phenyl pyrrolidine were designed based on generated QSAR equations. The carboxylesterase Notum inhibitory activity was predicted using the QSAR equations. The docking studies were carried out for designed compounds using Autodock against Carboxylesterase Notum esterase.

Conclusion: From the results, the designed compounds were found to inhibit Notum Carboxylase. Thus, the study led to the development of a novel lead compound for Carboxylesterase Notum.

Keywords: QSAR, MLR, carboxylesterase notum, validation, signalling, docking.

Graphical Abstract

[1]
Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434(7035): 843-50.
[http://dx.doi.org/10.1038/nature03319] [PMID: 15829953]
[2]
Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14(15): 1837-51.
[PMID: 10921899]
[3]
de Iongh RU, Abud HE, Hime GR. WNT/Frizzled signaling in eye development and disease. Front Biosci 2006; 11: 2442-64.
[http://dx.doi.org/10.2741/1982] [PMID: 16720326]
[4]
Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid- modified and can act as stem cell growth factors. Nature 2003; 423(6938): 448-52.
[http://dx.doi.org/10.1038/nature01611] [PMID: 12717451]
[5]
Chu ML, Ahn VE, Choi HJ, Daniels DL, Nusse R, Weis WI. structural Studies of Wnts and identification of an LRP6 binding site. Structure 2013; 21(7): 1235-42.
[http://dx.doi.org/10.1016/j.str.2013.05.006] [PMID: 23791946]
[6]
Fox S, Dharmarajan A. WNT signaling in malignant mesothelioma. Front Biosci 2006; 11: 2106-12.
[http://dx.doi.org/10.2741/1953] [PMID: 16720297]
[7]
Burrus LW, McMahon AP. Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties. Exp Cell Res 1995; 220(2): 363-73.
[http://dx.doi.org/10.1006/excr.1995.1327] [PMID: 7556445]
[8]
Mason JO, Kitajewski J, Varmus HE. Mutational analysis of mouse Wnt-1 identifies two temperature-sensitive alleles and attributes of Wnt-1 protein essential for transformation of a mammary cell line. Mol Biol Cell 1992; 3(5): 521-33.
[http://dx.doi.org/10.1091/mbc.3.5.521] [PMID: 1535241]
[9]
Serafino A, Moroni N, Zonfrillo M, et al. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer. Oncotarget 2014; 5(4): 978-92.
[http://dx.doi.org/10.18632/oncotarget.1571] [PMID: 24657851]
[10]
Kitajewski J, Mason JO, Varmus HE. Interaction of Wnt-1 proteins with the binding protein BiP. Mol Cell Biol 1992; 12(2): 784-90.
[http://dx.doi.org/10.1128/MCB.12.2.784]
[11]
Reichsman F, Smith L, Cumberledge S. Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J Cell Biol 1996; 135(3): 819-27.
[http://dx.doi.org/10.1083/jcb.135.3.819] [PMID: 8909553]
[12]
Kakugawa S, Langton PF, Zebisch M, et al. Notum deacylatesWnt proteins to suppress signalling activity. Nature 2015; 519(7542): 187-92.
[http://dx.doi.org/10.1038/nature14259] [PMID: 25731175]
[13]
Anthony CC, Robbins DJ, Ahmed Y, Lee E. Nuclear regulation of Wnt/β-Catenin signaling: it’s a complex situation. Genes (Basel) 2020; 11(8): 886.
[http://dx.doi.org/10.3390/genes11080886] [PMID: 32759724]
[14]
Sinha A, Fan VB, Ramakrishnan AB, Engelhardt N, Kennell J, Cadigan KM. Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2. Sci Adv 2021; 7(8): eabe0849.
[http://dx.doi.org/10.1126/sciadv.abe0849] [PMID: 33597243]
[15]
Fearon ER. Molecular genetics of colorectal cancer. Annual Rev Pathol 2011; 28(6): 479-507.
[http://dx.doi.org/10.1146/annurev-pathol-011110-130235]
[16]
Clevers H, Batlle E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res 2006; 66(1): 2-5.
[http://dx.doi.org/10.1158/0008-5472.CAN-05-3849] [PMID: 16397205]
[17]
Krishnan V, Bryant HU, MacDougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 2006; 116(5): 1202-9.
[http://dx.doi.org/10.1172/JCI28551] [PMID: 16670761]
[18]
Movérare-Skrtic S, Nilsson KH, Henning P, et al. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans. FASEB J 2019; 33(10): 11163-79.
[http://dx.doi.org/10.1096/fj.201900707R] [PMID: 31307226]
[19]
Brommage R, Liu J, Vogel P, et al. NOTUM inhibition increases endocortical bone formation and bone strength. Bone Res 2019; 7(1): 1-2.
[http://dx.doi.org/10.1038/s41413-018-0038-3]
[20]
Cheng X, Xu X, Chen D, Zhao F, Wang W. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. Biomed Pharmacother 2019; 110(110): 473-81.
[http://dx.doi.org/10.1016/j.biopha.2018.11.082] [PMID: 30530050]
[21]
Tanaka K, Kitagawa Y, Kadowaki T. Drosophila segment polarity gene product porcupine stimulates the posttranslational N-glycosylation of wingless in the endoplasmic reticulum. J Biol Chem 2002; 277(15): 12816-23.
[22]
Kadowaki T, Wilder E, Klingensmith J, Zachary K, Perrimon N. The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes & Devel 1996; 10(24): 3116-28.
[http://dx.doi.org/10.1101/gad.10.24.3116]
[23]
Lin X. Functions of heparan sulfate proteoglycans in cell signaling during development. Development 2004; 131(24): 6009-21.
[http://dx.doi.org/10.1242/dev.01522]
[24]
Bayle ED, Svensson F. Carboxylesterase Notum is a druggable target to modulate Wnt signaling. J Med Chem 2021; 64(8): 4289-311.
[http://dx.doi.org/10.1021/acs.jmedchem.0c01974]
[25]
Patel HM, Noolvi MN, Sharma P, et al. Quantitative structure–activity relationship (QSAR) studies as strategic approach in drug discovery. Med Chem Res 2014; 23(12): 4991-5007.
[http://dx.doi.org/10.1007/s00044-014-1072-3]
[26]
Mahy W, Patel M, Steadman D, et al. Screening of a custom-designed acid fragment library identifies 1-phenylpyrroles and 1-phenylpyrrolidines as inhibitors of Notum carboxylesterase activity. J Med Chem 2020; 63(17): 9464-83.
[http://dx.doi.org/10.1021/acs.jmedchem.0c00660]
[27]
Roy K, Mitra I. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design. Comb Chem High Throughput Screen 2011; 14(6): 450-74.
[http://dx.doi.org/10.2174/138620711795767893]
[28]
Roy K, Chakraborty P, Mitra I, Ojha PK, Kar S, Das RN. Some case studies on application of “rm2” metrics for judging quality of quantitative structure–activity relationship predictions: Emphasis on scaling of response data. J Comput Chem 2013; 34(12): 1071-82.
[http://dx.doi.org/10.1002/jcc.23231]